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Post-operative recurrence of mitral valve regurgitation after mitral valve repair may occur (1) . In this subgroup of patients, percutaneous treatment could be an option to avoid surgery. MitraClip implantation has been described (2) , and the feasibility of ViR implantation has been reported (3). A major concern of ViR is that the valve must accommodate an asymmetric oval-shaped ring and make it circular; a distortion of the valve itself may lead to regurgitation and/or to paravalvular regurgitation because of suboptimal apposition to the ring. We describe the first-in-man percutaneous transseptal closure of paravalvular regurgitation as a result of suboptimal apposition of the valve to the ring.
